Close
Nordic 9Nordic 9

Frazier Life Sciences (investor - Private Equity)

United States frazierls.com
See something wrong or missing? Let us know
Offices:San Francisco

Frazier Life Sciences is an American healthcare investment firm focusing on companies developing novel therapeutics from company formation to scale.

Average round investment:159.56M USD
Average number per year:2.0
Distribution: 2024 (2)
Portfolio companies: Switzerland Alentis TherapeuticsGermany Tubulis
Mostly invests in: Switzerland Switzerland (1) Biotech (2)

2 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Frazier Life Sciences

Name Criteria
United States Deep Track Capital
73%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Switzerland Nextech Invest
73%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Catalio Capital Management
73%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
United Arab Emirates Chimera Investment
73%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
Germany Hitachi Ventures
73%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
Germany KfW
72%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
Switzerland Endeavour Vision
72%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
United States Patient Square Capital
72%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
United Kingdom LGT Lightstone
71%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
United States Fidelity Investments
71%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 2.9
  • Active last 12 months: Yes
Top